To examine this effect in vivo, we established two animal models: one for subcutaneous tumor growth with varying levels of c-Myc expression and another employed a tail vein high-pressure c-Myc-plasmid injection to generate an orthotopic liver cancer model. The gene discussed is MYC; the disease is liver cancer.